Kura Oncology, Inc.

Historical 13F Holders

Symbol
KURA
CUSIP
50127T109
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 50127T109 since 12/18/2024, largest first.

Filer % of Class Filed
Montanova Capital, LLC 13G/A
9.7% 8/14/2026
Event 6/30/2026
BlackRock, Inc. 13G/A 8.9% 10/27/2026
Event 9/30/2026
Biotechnology Value Fund L P 13G/A
7.5% 11/16/2026
Event 9/30/2026
State Street Corp 13G 5.7% 2/9/2026
Event 12/31/2025
Vanguard Capital Management LLC 13G 5.0% 4/30/2026
Event 3/31/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (6)
RA Capital Management, L.P. 13G/A
4.9% 5/15/2025
Event 3/31/2025
EcoR1 Capital, LLC 13G/A
4.8% 8/14/2025
Event 6/30/2025
Armistice Capital, LLC 13G/A
4.2% 5/15/2026
Event 3/31/2026
James E. Flynn 13G/A
0% 2/13/2025
Event 12/31/2024
Paradigm Biocapital Advisors LP 13G/A
0% 2/14/2025
Event 12/31/2024
Vanguard Group Inc 13G/A 0% 3/27/2026
Event 3/13/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 234 88.8 M $950M
2026 Q2 222 86.9 M $953M
2026 Q1 222 84.4 M $686M
2025 Q4 217 85.4 M $888M
2025 Q3 200 83.9 M $743M
2025 Q2 184 82.1 M $474M
2025 Q1 185 80.4 M $531M
2024 Q4 187 78.8 M $686M
2024 Q3 181 82.4 M $1.61B
2024 Q2 177 80.5 M $1.66B
2024 Q1 170 80.8 M $1.72B
2023 Q4 142 78.8 M $1.13B
2023 Q3 135 75.3 M $687M
2023 Q2 151 75.1 M $795M
2023 Q1 143 72.5 M $885M
2022 Q4 143 70.1 M $870M
2022 Q3 150 71.6 M $977M
2022 Q2 152 68.7 M $1.26B
2022 Q1 154 66.7 M $1.11B
2021 Q4 154 64.1 M $898M
2021 Q3 157 66.7 M $1.25B
2021 Q2 174 67.6 M $1.41B
2021 Q1 174 68.6 M $1.94B
2020 Q4 206 65.1 M $2.13B
2020 Q3 163 53.8 M $1.65B
2020 Q2 135 52.4 M $856M
2020 Q1 120 39.8 M $395M
2019 Q4 129 39.0 M $537M
2019 Q3 117 40.2 M $610M
2019 Q2 123 38.7 M $762M
2019 Q1 105 32.0 M $531M
2018 Q4 100 32.4 M $455M
2018 Q3 119 30.3 M $530M
2018 Q2 109 29.8 M $542M
2018 Q1 98 23.6 M $442M
2017 Q4 76 19.5 M $299M
2017 Q3 66 19.4 M $290M
2017 Q2 44 10.8 M $101M
2017 Q1 35 10.3 M $90.7M
2016 Q4 30 9.88 M $58.2M
2016 Q3 28 9.75 M $60.9M
2016 Q2 25 9.32 M $25.2M
2016 Q1 20 10.2 M $41.4M
2015 Q4 14 10.2 M $86.1M